Adverse events associated with discontinuation of the biologics/classic systemic treatments for moderate-to-severe plaque psoriasis: data from the Spanish Biologics Registry, Biobadaderm
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adverse events associated with discontinuation of the biologics/classic systemic treatments for moderate-to-severe plaque psoriasis: data from the Spanish Biologics Registry, Biobadaderm
Authors
Keywords
-
Journal
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
Volume 31, Issue 10, Pages 1700-1708
Publisher
Wiley
Online
2017-05-09
DOI
10.1111/jdv.14314
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk of serious infections, cutaneous bacterial infections, and granulomatous infections in patients with psoriasis treated with anti–tumor necrosis factor agents versus classic therapies: Prospective meta-analysis of Psonet registries
- (2017) Ignacio Garcia-Doval et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Inclusion and exclusion criteria in phase III trials with systemic agents in psoriasis: the external validity of drug development
- (2016) N. Kirsten et al. BRITISH JOURNAL OF DERMATOLOGY
- Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest
- (2015) K. Reich et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
- (2015) Richard B. Warren et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Adverse events resulting in withdrawal of biologic therapy for psoriasis in real-world clinical practice: A Canadian multicenter retrospective study
- (2015) Whan B. Kim et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- ‘Happy’ drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTURE network
- (2014) J.M.P.A. van den Reek et al. BRITISH JOURNAL OF DERMATOLOGY
- Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris
- (2014) R. Gniadecki et al. BRITISH JOURNAL OF DERMATOLOGY
- Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national BIOBADADERM registry
- (2014) C. Medina et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5-year observational study of clinical practice: 2008-2013 results of the Biobadaderm registry
- (2014) G. Carretero et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Survival rate of antitumour necrosis factor-α treatments for psoriasis in routine dermatological practice: a multicentre observational study
- (2013) M. Esposito et al. BRITISH JOURNAL OF DERMATOLOGY
- Drug survival rates in patients with psoriasis after treatment with biologics
- (2013) Yoshinori Umezawa et al. JOURNAL OF DERMATOLOGY
- Risk of Serious Adverse Events Associated With Biologic and Nonbiologic Psoriasis Systemic Therapy
- (2012) Gregorio Carretero ARCHIVES OF DERMATOLOGY
- Long-term safety of biologics in the treatment of moderate-to-severe plaque psoriasis: review of current data
- (2012) M.H.A. Rustin BRITISH JOURNAL OF DERMATOLOGY
- Biologics for psoriasis: current evidence and future use
- (2012) C.E.M. Griffiths BRITISH JOURNAL OF DERMATOLOGY
- Drug survival rates of biologic treatments in patients with psoriasis vulgaris
- (2011) A.M.G. Brunasso et al. BRITISH JOURNAL OF DERMATOLOGY
- Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris
- (2011) R. Gniadecki et al. BRITISH JOURNAL OF DERMATOLOGY
- The Misperception That Clinical Trial Data Reflect Long-term Drug Safety
- (2009) Tamar Nijsten et al. ARCHIVES OF DERMATOLOGY
- British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009
- (2009) C.H. Smith et al. BRITISH JOURNAL OF DERMATOLOGY
- A new era in the management of psoriasis? The biologics: facts and controversies
- (2009) Carlos Ferrándiz et al. CLINICS IN DERMATOLOGY
- Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials
- (2008) J. Schmitt et al. BRITISH JOURNAL OF DERMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search